Short answer
Lifevantage Corp (LFVN) filed its Q3 2025 10-Q quarterly report on Nov 4, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $48M (up 0.7% year over year) with net income of $2M.
Q3 2025 key financials · XBRL
- Revenue
- $48M
- +0.7% YoY
- Net income
- $2M
- +18.0% YoY
- Operating margin
- 4.8%
- Gross margin
- 79.5%
- EPS (diluted)
- $0.17
- +21.4% YoY
Source: XBRL data from the Lifevantage Corp (LFVN) Q3 2025 10-Q on SEC EDGAR. USD.
Lifevantage Corp Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $47.6M, up 0.8% YoY from $47.2M, driven by MindBody GLP-1 System sales
- Gross margin 79.5% vs 79.9% YoY; commissions 43.5% vs 43.0% of revenue
- Americas revenue $37.2M, up 0.8%; Asia/Pacific & Europe $10.4M, up 0.4%
- Cash $13.1M vs $20.2M at June 30; operating cash use $2.3M vs $0.6M YoY
- Financing cash use $4.3M; continued MindBody GLP-1 expansion and LoveBiome assets expected to support growth, with active accounts down 1.6%
Risk Factors
- Risk Factors section not provided; no new or changed risks identifiable
- Stock repurchases: $44,364 shares purchased during the quarter
- Repurchase authorization: up to $60.0 million through December 31, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Lifevantage Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.